Related by context. Frequent words. (Click for all words.) 76 Paul Laikind 76 Drew Fromkin President 75 Patrik De Haes 75 David Aviezer 75 Neil K. Warma 74 Daniel Junius 74 Mark A. Sirgo 74 Kleanthis G. Xanthopoulos Ph.D. 73 Antony Koblish President 73 Steve Worland Ph.D. 72 Mark Hilz President 72 Dino Dina 72 Ron Bentsur 72 Dr. Bassam Damaj 72 Barry D. Quart 72 Michael V. Novinski 71 Anna Gluskin 71 Dr. Randall Yatscoff 71 Lonnie Moulder 71 Arthur S. Przybyl 70 Francois Nader 70 Dan Passeri Curis 70 Juergen Engel Ph.D. 70 Carl A. Pelzel 69 Sol J. Barer 69 Jack Lief 69 Steven A. Kriegsman 69 Brian A. Markison 69 Brian JG Pereira 69 Ronald Brus 68 Frank Condella 68 Mr. Weidong Yin 68 Dr Werner Lanthaler 68 Peter Riehl Stellar 68 A. Pontius 68 Thomas B. Okarma 68 Eamonn Hobbs 68 Edward Lanphier Sangamo 68 Patrick J. Balthrop 68 Kevin Buchi 67 Sachiko Kuno Ph.D. 67 Faheem Hasnain 67 Shlomo Yanai Teva 67 Peter J. Burlage 67 Dean Foate 67 Ron Najafi 67 Arthur Bedrosian president 66 J. Donald deBethizy 66 Hubert Yoshida vice 66 Tuan Ha Ngoc 66 Jeffrey H. Buchalter 66 Euan Thomson 66 Michael H. Tardugno 66 Philippe Calais 66 Onno van de Stolpe 66 Paul Cofoni CACI 66 Dr. Hassan Salari 66 Jack Zubarev founder 66 Jack Lief Arena 66 Ken Huseman Basic 66 Matthew Emmens 66 Tom Reslewic 66 Gil Van Bokkelen 66 David H. Fater 66 Ben Lipps 66 Ira L. Goldknopf 65 MultiCell Technologies 65 Christopher L. Coccio 65 Richard J. Meelia 65 Quay MD Ph.D. 65 Anthony DiTonno President 65 Glenn Saldanha 65 Melville Engle 65 Friedhelm Blobel Ph.D. 65 Daniel Vasella Chairman 65 Richard Verreault 65 Phillip DeZwirek Chairman 65 Wayne Gattinella 65 Burt Adelman 65 Martin M. Koffel 64 Roger Boissonneault 64 Bruce Kuhlik 64 Jeffery Yabuki 64 Kumar Chandrasekaran 64 Antoine Fournier 64 Jeff Morhet 64 Nasdaq PGNX today 64 Bohai Pharmaceuticals 64 Larry W. Reaugh 64 Joshua Boger 64 Abdul Ruff Colachal 64 Stephen McGibbon 64 Jerre Stead 64 Michael Narachi 64 Jim Mazzo 64 www.vivus.com 64 Dr. Rahul Singhvi 64 Duane D. Deaner 64 George A. Scangos 64 Paul Bisaro Watson 64 Discusses Q4